Perfusion and diffusion-weighted MR imaging in the early staging and the follow-up of patients with lung carcinoma;IRM de perfusion et de diffusion dans le bilan initial et le suivi des patients atteints de cancer bronchique

Revue de Pneumologie Clinique

Volumn 65, Issue 1, 2009, Pages 40-48

  Khalil, A ^a   Thomassin Naggara, I ^a   Gounant, V ^a   Nedelcu, N ^a   Marsault, C ^a   Carette, M F ^a  

^a HÔPITAL TENON   (France)

Author keywords

Diffusion weighted imaging; Lung cancer; MRI; Tissue perfusion

Indexed keywords

FLUORODEOXYGLUCOSE F 18; CONTRAST MEDIUM;

CANCER DIAGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; LUNG CARCINOMA; LUNG NODULE; METABOLISM; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; ARTICLE; LUNG TUMOR; METHODOLOGY; PATHOLOGY; VASCULARIZATION;

CONTRAST MEDIA; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING;

EID: 66149090421     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneumo.2008.08.001     Document Type: Review

References (28)

1. Morgan B., Thomas A.L., Drevs J., Hennig J., Buchert M., Jivan A., et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21 (2003) 3955-3964
2. Leach M.O., Brindle K.M., Evelhoch J.L., Griffiths J.R., Horsman M.R., Jackson A., et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92 (2005) 1599-1610
3. Walker-Samuel S., Leach M.O., and Collins D.J. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 51 (2006) 3593-3602
4. Le Bihan D., Breton E., Lallemand D., Grenier P., Cabanis E., and Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 161 (1986) 401-407
5. Charles-Edwards E.M., and de Souza N.M. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6 (2006) 135-143
6. Colagrande S., Carbone S.F., Carusi L.M., Cova M., and Villari N. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med (Torino) 111 (2006) 392-419
7. Koh D.M., and Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188 (2007) 1622-1635
8. O'Connor J.P., Jackson A., Parker G.J., and Jayson G.C. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96 (2007) 189-195
9. Provenzale J.M. Imaging of angiogenesis: clinical techniques and novel imaging methods. AJR Am J Roentgenol 188 (2007) 11-23
10. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
11. Padhani A.R., and Husband J.E. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 56 (2001) 607-620
12. Kiessling F., Jugold M., Woenne E.C., and Brix G. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Eur Radiol 17 (2007) 2136-2148
13. Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24 (2006) 3293-3298
14. Kono R., Fujimoto K., Terasaki H., Müller N.L., Kato S., Sadohara J., et al. Dynamic MRI of solitary pulmonary nodules: comparison of enhancement patterns of malignant and benign small peripheral lung lesions. AJR Am J Roentgenol 188 (2007) 26-36
15. Morgan B., Utting J.F., Higginson A., Thomas A.L., Steward W.P., and Horsfield M.A. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 94 (2006) 1420-1427
16. Schaefer J.F., Schneider V., Vollmar J., Wehrmann M., Aebert H., Friedel G., et al. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer 53 (2006) 39-49
17. Ohno Y., Hatabu H., Takenaka D., Adachi S., Kono M., and Sugimura K. Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 224 (2002) 503-511
18. Kim J.H., Kim H.J., Lee K.H., Kim K.H., and Lee H.L. Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 28 (2004) 766-775
19. Schaefer J.F., Vollmar J., Schick F., Vonthein R., Seemann M.D., Aebert H., et al. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology 232 (2004) 544-553
20. Fujimoto K., Abe T., Muller N.L., Terasaki H., Kato S., Sadohara J., et al. Small peripheral pulmonary carcinomas evaluated with dynamic MR imaging: correlation with tumor vascularity and prognosis. Radiology 227 (2003) 786-793
21. Horsfield M., Morgan B., Stattaus J., Khalil A., Oberholzer K., Gauler T., et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line monotherapy in patients with Stage IIIB or Stage IV non-small cell lung cancer (NSCLC)ESMO 2006. Ann Oncol 17 (2006) ix219
22. Stejkal E.O., and Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 42 (1965) 88-292
23. Uhl M., Altehoefer C., Kontny U., Il'yasov K., Buchert M., and Langer M. MRI-diffusion imaging of neuroblastomas: first results and correlation to histology. Eur Radiol 12 (2002) 2335-2338
24. Matoba M., Tonami H., Kondou T., Yokota H., Higashi K., Toga H., et al. Lung carcinoma: diffusion-weighted mr imaging-preliminary evaluation with apparent diffusion coefficient. Radiology 243 (2007) 570-577
25. Fujisawa H., Kushihashi T., Takenaka H., Usui N., Baba M., and Ukisu R. Diffusion-weighted MR imaging of various chest diseases using single shot fast spin echo: its advantages and prospect for clinical using. Proceeding RSNA (2006) 700
26. Ohno Y., Koyama H., Nogami M., Takenaka D., Yoshikawa T., and Fujii M. Whole-body diffusion-weighted MR imaging: utility for assessment of M-stage in lung cancer patients as compared with standard whole-body MR imaging and FDG-PET. Proceeding RSNA (2006) 686
27. Thoeny H.C., De Keyzer F., Chen F., Vandecaveye V., Verbeken E.K., Ahmed B., et al. Diffusion-weighted magnetic resonance imaging allows non invasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration. Neoplasia 7 (2005) 779-787
28. Hayashida Y., Yakushiji T., Awai K., Katahira K., Nakayama Y., Shimomura O., et al. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol 16 (2006) 2637-2643